Comparison

PneumoRecs VaxAdvisor vs MCT2D

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

PneumoRecs VaxAdvisor

This application offers personalized pneumococcal vaccination guidance based on patient age, vaccination history, and medical conditions. It aligns with the Advisory Committee on Immunization Practices' recommendations for U.S. immunization schedules.

Highlights
  • Patient-specific vaccination recommendations
  • Age-based guidance
  • Vaccination history tracking
  • Underlying medical condition prompts
  • U.S. immunization schedule compliance
Features
Read full description

This is the PneumoRecs VaxAdvisor App created by the Centers for Disease Control and Prevention (CDC) in collaboration with the Georgia Tech Research Institute. PneumoRecs VaxAdvisor provides patient-specific pneumococcal vaccination guidance consistent with the pneumococcal vaccination recommendations of the Advisory Committee on Immunization Practices. Vaccination providers enter a patient’s age and respond to prompts about the patient’s pneumococcal vaccination history and underlying medical conditions. The app then displays patient-specific pneumococcal vaccination recommendations consistent with the recommended U.S. immunization schedule.

About

MCT2D

This app provides resources and tools for managing type 2 diabetes. It includes a coverage checker for medications and devices, a library of curated resources for patients and providers, and news updates. Users can also register for learning community events.

Highlights
  • Coverage checker for medications and devices
  • Curated resource library
  • News articles
  • Learning community event registration
  • Filterable resources
  • Bookmarking favorite tools
Features
Read full description

The Michigan Collaborative for Type 2 Diabetes (MCT2D) was established in 2021 to accelerate a new way forward, through collaboration, innovation, and investment in quality, evidence based care for type 2 diabetes. MCT2D strives to remove barriers to guideline concordant care, support participating practices, and keep patients central to quality improvement work. The MCT2D app provides much of the same information for our participating members and for members of the public as our website, mct2d.org, in a condensed format. The app provides a registration link to our next upcoming learning community event, news articles published by the team, a condensed version of our Coverage Checker tool, and our growing collection of resources for providers and patients based on our CGM, medication, and low carb diet initiatives. More details on each part of our app are below. Coverage Checker MCT2D collects and maintains a curated set of coverage data for CGM, GLP-1 RA & GIP, and SGLT2i medications for specific popular medical plans in the state of Michigan. Users can select a product type, plan type, and plans from the dropdown lists. After making their selections, the user is presented with a list of preferred and non-preferred options covered by their selected plan. If available, there are also links to formularies or other relevant documents. Tools & Resources MCT2D's curated selection of resources is adapted for easy access on the mobile screen. As with the resource library at mct2d.org/resource-library, the resources are filterable by various categories. For specific resources, mobile-specific versions of the tools have been designed to be more readable on a phone screen. Users can also bookmark their favorite tools for quick access later. Optionally, users can share links to these resources via email or text by providing a phone number or email. We do not share this data with anyone. MCT2D News All news articles published on mct2d.org are also available in the app. Filters are also provided to help users find specific categories of news.

Screenshots

PneumoRecs VaxAdvisor2 screens
MCT2D4 screens

Verdict

The call

The clearest difference is review sentiment: MCT2D at 100% against PneumoRecs VaxAdvisor's 27%. MCT2D also leads on rating (5.0 vs 3.4) and update cadence (every 5 weeks vs every 3 months). PneumoRecs VaxAdvisor's advantage is ratings volume (60 vs 2). On price, ads, in-app purchases and monetization model there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

MCT2D holds the better App Store score, 5.0 against 3.4. That said, the two scores are not equally well evidenced: PneumoRecs VaxAdvisor has 60 ratings behind it against 2, so its average is the more settled of the two. Written reviews point the same way: 27% of PneumoRecs VaxAdvisor's written reviews are positive against 100% of MCT2D's.

UpkeepUpdate frequency

PneumoRecs VaxAdvisor ships an update every 3 months, MCT2D every 5 weeks. The most recent releases landed on August 28, 2026 and September 9, 2026 respectively.

Scorecard5 real differences · 5 level
PneumoRecs VaxAdvisor versus MCT2D: the parameters behind the verdict, then further details
ParameterPneumoRecs VaxAdvisorMCT2D
PriceFreeFree
Rating3.4 (60 ratings)5.0 (2 ratings) — better
Positive reviews26.9% of reviews100.0% of reviews — better
Number of ratings60 — better2
Update frequencyEvery 3 monthsEvery 5 weeks — better
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS18.015.1 — better
Further details — not scored
Size6 MB33 MB
Age rating17+17+
DeveloperCenters For Disease Control and PreventionThe University of Michigan

Customer experience

PneumoRecs VaxAdvisor

All ratings60 ratings
Positive58.3%
Neutral3.3%
Negative38.3%
Written reviews26 reviews
Positive26.9%
Neutral11.5%
Negative61.5%

MCT2D

All ratings2 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews1 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

PneumoRecs VaxAdvisor

No in-app purchases

None

MCT2D

No in-app purchases

Questions

Is PneumoRecs VaxAdvisor free?
PneumoRecs VaxAdvisor is free to download, with no in-app purchases.
Is MCT2D free?
MCT2D is free to download, with no in-app purchases.
Which has better reviews, PneumoRecs VaxAdvisor or MCT2D?
MCT2D is rated higher. PneumoRecs VaxAdvisor averages 3.4 out of 5 from 60 ratings, while MCT2D averages 5.0 from 2 ratings.
Do PneumoRecs VaxAdvisor or MCT2D have ads?
Neither PneumoRecs VaxAdvisor nor MCT2D shows ads.
Which is updated more often, PneumoRecs VaxAdvisor or MCT2D?
PneumoRecs VaxAdvisor ships an update every 3 months, and MCT2D every 5 weeks. Most recently, PneumoRecs VaxAdvisor was updated on August 28, 2026 and MCT2D on September 9, 2026.

Other comparisons